Insider · CIK 0001787403
Preetam Shah
Files at ELTX (Elicio Therapeutics, Inc.). First filing -, latest -.
Preetam Shah files SEC Form 4 as officer at ELTX (Elicio Therapeutics, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Preetam Shah has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 3 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Feb 2, 2026 | ELTX Elicio Therapeutics, Inc. | AGrant or award Common Stock | +24,000 | $0.00 | $0 | 24,000 | Feb 3, 2026 |
| Feb 2, 2026 | ELTX Elicio Therapeutics, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +47,900 | $0.00 | $0 | 47,900 | Feb 3, 2026 |
| Apr 15, 2025 | ELTX Elicio Therapeutics, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +191,624 | $0.00 | $0 | 191,624 | Apr 16, 2025 |
Questions about Preetam Shah
Answered from the filings on this page, as of the latest one.
Is Preetam Shah buying or selling?
Preetam Shah has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Preetam Shah's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Preetam Shah has 0.
Where does Preetam Shah file Form 4?
Preetam Shah has filed Form 4 at ELTX (Elicio Therapeutics, Inc.) as See Remarks. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.